FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:333 January 29, 1998 Number 5 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: Human T-cell lymphotropic virus type I (HTLV-I) is the causative agent of adult T-cell leukemia–lymphoma (ATL) and HTLV-I–associated myelopathy–tropical spastic paraparesis (HAM–TSP), a neurologic disorder. The virus is transmitted through sexual contact, breast-feeding, and blood transfusion. We describe a patient with both ATL and HAM–TSP, which developed during a complete remission of acute myelogenous leukemia.

A 70-year-old heterosexual man, who had been born and lived in an area of Japan where HTLV-I was not endemic, was admitted to our hospital in June 1985. Acute myelogenous leukemia was diagnosed, and he received numerous blood transfusions for two years . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Corral, L. G., Haslett, P. A. J., Muller, G. W., Chen, R., Wong, L.-M., Ocampo, C. J., Patterson, R. T., Stirling, D. I., Kaplan, G. (1999). Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-{alpha}. J. Immunol. 163: 380-386 [Abstract] [Full Text]  
• Goodnough, L. T., Brecher, M. E., Kanter, M. H., AuBuchon, J. P. (1999). Transfusion Medicine -- Blood Transfusion- First of Two Parts. NEJM 340: 438-447 [Full Text]